NRx Pharmaceuticals (NRXP) Revenue & Revenue Breakdown
NRx Pharmaceuticals Revenue Highlights
NRx Pharmaceuticals Revenue by Period
NRx Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
NRx Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
NRx Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $8.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | - |
NRx Pharmaceuticals generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
NRx Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SNTI | Senti Biosciences | $2.56M | - |
| NTRB | Nutriband | $2.09M | $442.83K |
| BLCM | Bellicum Pharmaceuticals | $1.50M | $1.00M |
| LGVN | Longeveron | $709.00K | $548.00K |
| ADTX | Aditxt | $645.18K | $44.28K |
| LEXX | Lexaria Bioscience | $226.21K | $84.00K |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| CING | Cingulate | - | - |
| HILS | Tharimmune | - | - |
| RNXT | RenovoRx | - | - |
| NRXP | NRx Pharmaceuticals | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
NRXP Revenue FAQ
What is NRx Pharmaceuticals’s yearly revenue?
NRx Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. NRXP's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is NRx Pharmaceuticals’s quarterly revenue?
NRx Pharmaceuticals's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). NRXP's quarterly revenue for Q4 2023 was $8K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is NRx Pharmaceuticals’s revenue growth rate?
NRx Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.